Mostrar el registro sencillo del ítem
dc.contributor.author | Marchand, Pascal | |
dc.contributor.author | Bazin, Marc-Antoine | |
dc.contributor.author | Pagniez, Fabrice | |
dc.contributor.author | Riviere, Guillaume | |
dc.contributor.author | Bodero, Lizeth | |
dc.contributor.author | Marhadour, Sophie | |
dc.contributor.author | Nourrisson, Marie-Renee | |
dc.contributor.author | Picot, Carine | |
dc.contributor.author | Ruchaud, Sandrine | |
dc.contributor.author | Bach, Stephane | |
dc.contributor.author | Baratte, Blandine | |
dc.contributor.author | Sauvain, Michel Henri Auguste | |
dc.contributor.author | Pareja, Denis Castillo | |
dc.contributor.author | Vaisberg Wollach, Abraham Jaime | |
dc.contributor.author | Le Pape, Patrice | |
dc.date.accessioned | 2019-02-06T14:52:34Z | |
dc.date.available | 2019-02-06T14:52:34Z | |
dc.date.issued | 2015 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12866/5310 | |
dc.description.abstract | A series of original 2-phenyl-3-(pyridin-4-yl)imidazo[1,2-a]pyrazines and the 3-iodo precursors, bearing a polar moiety at the C-8 position, was synthesized and evaluated for their antileishmanial activities. Two derivatives exhibited very good activity against the promastigote and the amastigote forms of Leishmania major in the micromolar to submicromolar ranges, coupled with a low cytotoxicity against macrophages and 3T3 mouse fibroblast cells. Through LmCK1 inhibition assay, investigations of the putative molecular target of these promising antileishmanial compounds will be discussed. | en_US |
dc.language.iso | eng | |
dc.publisher | Elsevier | |
dc.relation.ispartofseries | European Journal of Medicinal Chemistry | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
dc.subject | Humans | en_US |
dc.subject | Animals | en_US |
dc.subject | Molecular Structure | en_US |
dc.subject | Mice | en_US |
dc.subject | Dose-Response Relationship, Drug | en_US |
dc.subject | Fibroblasts/drug effects | en_US |
dc.subject | Mice, Inbred BALB C | en_US |
dc.subject | Cell Line | en_US |
dc.subject | Antileishmanial activity | en_US |
dc.subject | Antiprotozoal Agents/chemical synthesis/chemistry/pharmacology | en_US |
dc.subject | Casein kinase 1 | en_US |
dc.subject | Cell Proliferation/drug effects | en_US |
dc.subject | Direct arylation | en_US |
dc.subject | Imidazo[1,2-a]pyrazines | en_US |
dc.subject | Imidazoles/chemical synthesis/chemistry/pharmacology | en_US |
dc.subject | Leishmania major/drug effects | en_US |
dc.subject | Macrophages/drug effects | en_US |
dc.subject | Pyrazines/chemical synthesis/chemistry/pharmacology | en_US |
dc.subject | Structure-Activity Relationship | en_US |
dc.title | Synthesis, antileishmanial activity and cytotoxicity of 2,3-diaryl- and 2,3,8-trisubstituted imidazo[1,2-a]pyrazines | en_US |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | https://doi.org/10.1016/j.ejmech.2015.09.002 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.01.06 | |
dc.relation.issn | 1768-3254 |
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |